Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
42
NCT00085163
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
Phase: Phase 3
Role: Collaborator
Start: Mar 31, 2004
Completion: Not specified
NCT04953377
PFMT Educational Intervention for Patients With Advancer Breast Cancer
Phase: N/A
Role: Lead Sponsor
Start: Sep 2, 2021
Completion: Apr 10, 2023